You have 9 free searches left this month | for more free features.

mfolfirinox

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • mFOLFIRINOX
  • Gemcitabine / Nab-paclitaxel
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Non-resectable
  • SBRT+mFOLFIRINOX
  • mFOLFIRINOX
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 24, 2022

Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • mFOLFIRINOX
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Feb 14, 2022

Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

Recruiting
  • Borderline Resectable Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • Nab paclitaxel plus gemcitabine
  • mFOLFIRINOX
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • mFOLFIRINOX
  • +7 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)

Not yet recruiting
  • Locally-advanced Rectal Cancer
  • mFOLFIRINOX
  • +6 more
  • Lyon, Rhöne, France
  • +1 more
Jun 12, 2023

Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,

Recruiting
  • Unresectable Pancreatic Cancer
  • Suizenji
  • +3 more
  • Sendai-shi, Miyagi, Japan
  • +2 more
Jan 31, 2023

Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)

Recruiting
  • Colorectal Cancer Stage IV
  • mFOLFIRINOX
  • Sao Paulo, SP, Brazil
    ICESP
Apr 28, 2022

Early Luminal Breast Cancer and Pancreatic Cancer Patients

Recruiting
  • Breast Cancer
  • Pancreas Cancer
  • mFOLFIRINOX
  • +4 more
  • Moscow, Not Required, Russian Federation
    Moscow Clinical Scientific Center named after AS Loginov
Oct 12, 2022

Pancreatic Cancer Trial in Australia (radiation, drug, procedure)

Recruiting
  • Pancreatic Cancer
  • Stereotactic Radiotherapy (SBRT)
  • +4 more
  • Camperdown, New South Wales, Australia
  • +10 more
Oct 15, 2021

Pancreatic Carcinoma Trial in France (drug, radiation, procedure)

Recruiting
  • Pancreatic Carcinoma
  • mFolfirinox
  • +3 more
  • Bordeaux, France
  • +27 more
Mar 29, 2022

Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)

Recruiting
  • Stage III Colon Cancer
  • Signatera test
  • +5 more
  • Pittsburgh, Pennsylvania
    NRG Oncology - Pittsburgh Center
Mar 30, 2022

Resected Pancreatic Adenocarcinoma Trial in Washington (mFOLFIRINOX, Proton beam radiation)

Recruiting
  • Resected Pancreatic Adenocarcinoma
  • mFOLFIRINOX
  • Proton beam radiation
  • Washington, District of Columbia
    Georgetown University Medical Center - Lombardi Comprehensive Ca
Jul 27, 2021

Pancreatic Adenocarcinoma (Ductal Adenocarcinoma) Trial in Canada, France (mFolfirinox, Gemcitabine)

Completed
  • Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
  • Calgary, Alberta, Canada
  • +51 more
Jan 3, 2022

Advanced Pancreatic Cancer Trial in Shanghai, Hangzhou (Fluzoparib, Fluzoparib , mFOLFIRINOX)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, Shanghai, China
  • +1 more
Aug 9, 2020

Pancreas Ductal Adenocarcinoma Trial in Italy (PAXG, mFOLFIRINOX, short-course chemo)

Recruiting
  • Pancreas Ductal Adenocarcinoma
  • Aviano, Italy
  • +21 more
Mar 10, 2021

Pancreatic Adenocarcinoma Trial (Nab paclitaxel, Gemcitabine, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Apr 6, 2021

Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jan 12, 2022

Cancer of the Rectum Trial in France (drug, radiation, procedure)

Active, not recruiting
  • Cancer of the Rectum
  • mFolfirinox
  • +4 more
  • Amiens, France
  • +35 more
Jul 20, 2021

Bile Duct Cancer Trial in France (GEMCIS, mFolfirinox)

Completed
  • Bile Duct Cancer
  • Amiens, France
  • +41 more
Feb 23, 2022

Metastatic Pancreatic Cancer Trial in Guangzhou (mFOLFIRINOX)

Unknown status
  • Metastatic Pancreatic Cancer
  • mFOLFIRINOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2019